Verastem climbs on Q2 beat as new ovarian cancer drug boosts topline Verastem climbs on Q2 beat as new ovarian cancer drug boosts topline Post ContentvstmRead More You might also be interested in reading Why Cardano (ADA) May Breakout In A Bull Run To $1. August 8, 2025 In Mainstream ← Previous post Next post →